|
Studies |
Methods |
Participants |
Cause of Renal Failure |
Intervention |
Outcomes |
Follow-up | (T/C) | Age | M/F | T | C |
| Chen 2011 [32] | D: RCT R: NM A: NM B: NM | 36 (18/18, 216/216*) | () () | 11/17 | NM | 00:00 SFI 20 mL + 0.9% NS 130 mL | 00:00 0.9% NS 150 mL | HI, BP, Dry weight | 4 w |
|
Liang et al., 2011 [33] | D: RCT R: Random-number table A: N B: N | 46 (23/23, 240/240*) | () () | 31/15 | 21 CGN 13 DN, 7 ON, 3 HN, 2 GN | SOS: SFI 40 mL + CT | SOS: CT | BP, HR, ALB, CRP, Clinical effect | 3-4 w |
|
Li 2012 [34] | D: RCT R: Random- number table A: N B: N | 34 (18/16, 468/416*) | () () | 23/11 | NM | SOS: SFI 40 mL + CT | SOS: CT | HI, SBP, DBP, ALB, CRP. | 12 w |
|
Ma and Fu 2011 [35] | D: RCT R: NM A: NM B: NM | 40 (20/20, 720/696*) | 29–72 (56.6) 30–74 (56.8) | 27/13 | 20 CGN 6 DN, 3 ON, 9 HN, 2 O | 00:00 SFI 40 mL SOS: CT | SOS: CT | HI, Clinical symptom | 12 w |
| Ouyang 2009 [36] | D: RCT R: NM A: NM B: NM | 30 (15/15, 150/150*) | () () | 13/17 | NM | 02:00 SFI 50 mL + 0.9% NS 250 mL | 02:00 0.9% NS 300 mL | BP, CS, Intervention for IDH | 3–5 w |
|
Zeng and Xian 2007 [37] | D: RCT R: Computer Software A: N Bi: N | 60 (40/20, 1440/720*) | () () | 33/27 | 28 CGN 11 DN, 12 ON, 3 HN, 6 O | SOS: SFI 20 mL + 50 g/L GS 30 mL | SOS: 50 g/L GS 30 mL | BP, HR, ALB, SE, HI, CRP, Serum osmolality | 12 w |
| Zhao 2012 [38] | D: RCT R: Random- number table A: N B: N | 52 (29/23) | () () | 33/19 | 27 CGN 9 DN, 3 ON, 7 HN, 6 O | 00:00 SFI 50 mL + 0.9% NS 50 mL | 00:00 0.9% NS 100 mL | BP, ALB, SCR, HI, BUN, HB, ultrafiltration volume | 12 w |
|
Zhong et al., 2013 [39] | D: RCT R: Random- number table A: N B: N | 55 (25/25, 250/250*) | () () | 23/27 | 7 CGN, 24 DN, 14 HN, 1 GN, 6 O | 00:10 & 02:00: SFI 20 mL + 50% GS 20 mL | 00:10 & 02:00 0.9% NS 40 mL | CS, Side effect. | 3–5 w |
|
|